Skip to content

End-of-life Intervention for African American Dementia Caregivers

Community-based End-of-Life Intervention for African American Dementia Caregivers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03323411
Enrollment
355
Registered
2017-10-27
Start date
2013-08-15
Completion date
2019-05-31
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Encephalopathy, Ischemic

Brief summary

In a community-based approach, the investigators long-term goal is to empower African American family caregivers who are designated healthcare proxies to make informed end-of-life treatment decisions for participants with moderate to severe dementia before a life-threatening medical crisis occurs.

Detailed description

The investigators conducted a randomized controlled trial for efficacy of the Advance Care Treatment Program in an African American church-based community model. The investigators compared the effect of the experimental and control groups on knowledge, self-efficacy, intentions and behaviors from 4 urban African American churches randomly assigned to experimental (n=2) or control (n=2) conditions,304 (experimental n=152; control (n=152) health care proxies of participants that have advanced stage dementia: (a) were concurrently recruited in small classes each with 8-9 healthcare proxies.

Interventions

BEHAVIORALAdvance Care Treatment Plan

subjects in experimental group are taught information on dementia mechanical ventilation tube feeding and cardiopulmonary resuscitation

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Caregiver spouse or adult child of care recipient * Caregiver knowledgeable about care recipient's medical history * Care recipient must be African American * Care recipient must have moderate to severe stage dementia * Care recipient must lack decisional capacity

Exclusion criteria

* Not a caregiver * Care recipient not African American, * Care recipient without moderate to severe dementia

Design outcomes

Primary

MeasureTime frameDescription
Knowledge of dementiaThree yearsKnowledge of Dementia Scale measures Knowledge of dementia with 17 dichotomous true/false items, maximum total score = 17 and Cronbach's α=.76. Higher scores indicate greater practical understanding of dementia knowledge
Knowledge of cardiopulmonary resuscitation (CPR), mechanical ventilation (MV), tube feeding (TF)Three yearsKnowledge of CPR, MV, and TF Scale mmeasures CPR, MV and TF with 18-items Likert (5-point) and yes/no questions. Higher scores indicate increased general knowledge of CPR, MV and TF.
Self efficacyThree yearsConfidence in Treatment Decisions Made Scale measures self-efficacy on decision choices for CPR, MV, and TF with12-item Likert scale (1=extremely comfortable to 5=not at all comfortable) and Cronbach α=.93
Intention to make a Care PlanThree yearsTreatment Decisions Questionnaire measured Intention to make a Care Plan using the 3-item dichotomous (yes/no) items on each CPR, MV and TF.

Secondary

MeasureTime frameDescription
Written Care Plan3 yearsTreatment Decision Questionnaire 3 items dichotomous yes/no measuring actual care plan implemented on CPR, MV, TF

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026